Novavax Inc vs Tapestry, Inc. — how do they compare? Novavax Inc trades at $8.06 (market cap $1.30B), while Tapestry, Inc. trades at $140.62 (market cap $28.51B). The key difference: Tapestry, Inc. is far larger — about 21.9× Novavax Inc's market cap, and Tapestry, Inc. pays a 1.13% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| NVAX | TPR | |
|---|---|---|
Market Cap | $1.30B | $28.51B |
Sector | Health | Consumer Cyclical |
52-Week High | $11.19 | $160.49 |
52-Week Low | $6.22 | $95.69 |
Enterprise Value | $800.50M | $31.37B |
Dividend Yield | — | 1.13% |
Trailing returns across standard periods
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →Coach, Kate Spade, and Stuart Weitzman are the fashion and accessory brands that comprise Tapestry. The firm's products are sold through about 1,400 company-operated stores, wholesale channels, and e-commerce in North America (67% of fiscal 2022 sales), Europe, Asia (28% of fiscal 2022 sales), and elsewhere. Coach (74% of fiscal 2022 sales) is best known for affordable luxury leather products. Kate Spade (22% of fiscal 2022 sales) is known for colorful patterns and graphics. Women's handbags and accessories produced 69% of Tapestry's sales in fiscal 2022. Stuart Weitzman, Tapestry's smallest brand, generates nearly all its revenue from women's footwear.
Read more on TPR →